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OBJECTIVES The goal of this study was to determine the relative prognostic importance of noninvasive
measures of endothelial function and atheroma burden in patients with coronary artery disease
(CAD).
BACKGROUND Direct measurement of atherosclerosis by carotid ultrasound and endothelial function
assessment by brachial artery flow-mediated dilation (FMD) have both been shown to predict
vascular events. The combined prognostic utility of carotid ultrasound and FMD relative to
traditional risk markers and cardiovascular fitness has not been evaluated.
METHODS A total of 152 patients with CAD underwent metabolic testing, exercise stress tests, carotid
ultrasound, and endothelial function measurements.
RESULTS Patients were followed for 34  10 months during which 22 vascular events occurred. Peak
FMD (p 0.012) and FMD/nitroglycerin-mediated dilation (NMD) ratio (p 0.008) were
lower in subjects with events. Univariate analysis with Cox proportional hazards modeling
identified plaque area (p  0.0047), total area (p  0.0085), peak FMD (p  0.01),
FMD/NMD ratio (p  0.008), stress test workload (p  0.027), long-acting nitroglycerin
(NTG) (p  0.0071), and calcium blockers (p  0.0057) as predictors of adverse events.
Multivariate analysis showed that FMD/NMD ratio (p  0.0001), carotid plaque area (p 
0.06), and NTG (p  0.005) were independent predictors. Based on median values, subjects
were divided into high and low “plaque burden” groups and into high and low FMD/NMD
subgroups. Patients with high FMD/NMD had low event rates irrespective of the degree of
carotid atheroma. Patients with low FMD/NMD and high “plaque burden” had the highest
event rate (p  0.05).
CONCLUSIONS The structural and functional status of the vasculature are independent predictors of coronary
events as shown by noninvasive measurement of endothelial function and carotid atheroma
burden in patients with CAD. Preserved endothelial function attenuates the risk of future
events associated with a high plaque burden. (J Am Coll Cardiol 2003;42:1037–43) © 2003
by the American College of Cardiology Foundation
Risk stratification for the development of cardiovascular
disease or the occurrence of vascular events is a complex
process made even more complex by the steady and rapid
emergence of new biochemical markers and imaging meth-
ods. Endothelial dysfunction is both an early marker of
vascular disease and a facilitative process in the development
of atherosclerosis (1,2). Some evidence indicates that the
presence and degree of endothelial dysfunction are of
prognostic importance (3–11). But these early results are
tempered by the paucity of studies utilizing noninvasive
methods (4,6,9). Moreover, one of these studies failed to
show that noninvasively measured endothelial dysfunction
was of independent prognostic importance when considered
in a multivariate model that included the extent of angio-
graphic coronary vessel disease (9). In the other two studies,
no alternative imaging methods were considered, and so the
independent value of risk stratification based on noninvasive
endothelial function assessment could not be determined
(4,6). One of the studies focused solely on hypertensive
postmenopausal women and excluded women without de-
pressed endothelial function (6). And finally, one study was
limited to a follow-up period of only 30 days after elective
vascular surgery (4).
The purpose of this investigation was to assess the
prognostic value of noninvasive endothelial function mea-
surement in a broader population of patients with coronary
artery disease (CAD). Our main goal was to assess the
additional value of this potential method of risk stratifica-
tion within a context of alternative, noninvasive methods,
particularly exercise stress testing or carotid ultrasound
measures of atheroma burden.
METHODS
Patient population. Subjects were recruited from consec-
utive patients enrolled in a lifestyle modification program
who were able to exercise and willing to undergo extensive
biochemical and imaging assessment. All subjects had
known CAD as defined by one of history of myocardial
infarction (MI), previous percutaneous coronary angioplasty
From the *Division of Cardiology, Department of Medicine, †Department of
Statistics, and ‡Department of Laboratory Medicine, University of British Columbia,
Vancouver, British Columbia, Canada. Supported, in part, by an unrestricted
educational grant by Merck Frosst Canada.
Manuscript received January 15, 2003; revised manuscript received May 16, 2003,
accepted May 21, 2003.
Journal of the American College of Cardiology Vol. 42, No. 6, 2003
© 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00
Published by Elsevier Inc. doi:10.1016/S0735-1097(03)00927-6
(PTCA), previous coronary artery bypass grafting (CABG),
positive myocardial perfusion scan, or positive exercise stress
test (EST).
Baseline assessment. All subjects underwent metabolic
testing including lipids, glucose, and homocysteine. Lipids
and apolipoprotein B were measured by enzymatic and
apolipoprotein B by a nephelometric method on fasting
samples. Lipoprotein (a) concentration was measured with
an immunoassay (Mercodia AB, Uppsala, Sweden) of apo-
lipoprotein (a). Glucose was measured by a standard enzy-
matic method. Total homocysteine was measured by en-
zyme immunoassay (Abbott Diagnostics, Abbott Park,
Illinois). All subjects underwent an EST using the Bruce
protocol.
Carotid ultrasound studies. All subjects underwent ca-
rotid ultrasound for evaluation of intima medial thickness
(IMT) and plaques. Carotid scans were acquired using
high-resolution ultrasound (Sonos 5500, Agilent Technol-
ogies, Palo Alto, California) and a 10-MHz linear array
transducer as described previously (12,13). Longitudinal
views of the left and right common carotid, carotid bifur-
cations, internal and external carotid arteries were obtained
and recorded on super VHS tapes. All ultrasound studies
(carotid and brachial flow-mediated dilation [FMD]) were
analyzed off-line by specially trained technicians blinded to
other study variables using the Prosound system (13); IMT
was measured over 10 mm in the far wall of the common
carotid within 2 cm proximal to the bulb. The region with
the thickest IMT without focal lesions was measured. Left
and right carotid IMT were averaged. Intima medial area
was defined as: (IMT mm)  (length over which IMT was
measured [20 mm])  intima medial area in mm2. Plaques
were quantified in all carotid segments (common, internal,
and external carotid arteries). Plaque was defined as any
focal protrusion above the intima. Plaque thickness was
defined as the sum of the maximal thickness of all plaques.
Plaque area was calculated as the sum of the total area of all
plaques. We also integrated IMT and plaque measurements
as follows: 1) total area was defined as the sum of all
plaque areas and the areas of IMT measured in both left and
right carotid arteries (i.e., over 10 mm in each), and 2) total
thickness was defined as the total area divided by the total
length of plaques plus the length of the regions used to
measure IMT (i.e., 20 mm). The intra- and interobserver
variations in our laboratory have been published (12). For
intraobserver measurements, the accuracy was between
0.019 and 0.014 mm with a precision of 0.049 to
0.089 mm. For interobserver measurements, the accuracy
was between 0.003 to 0.000 mm with a precision of 0.040
to 0.051 mm. Plaque length and average plaque thickness
are measured with a precision of 1.37 mm and 0.4 mm,
respectively.
Endothelial function studies. Endothelial function was
assessed with brachial artery FMD as modified from Cel-
ermajer et al. (14). This assessment was not available in the
first 28 patients enrolled in the program but was performed
in the subsequent 124 patients. Studies were carried out
after an overnight fast. Vasoactive medications were with-
held on the day of the study. The brachial artery was imaged
using the same equipment as carotid studies and imaged in
the mid-upper arm. Baseline diameter was measured; FMD
was induced by occlusion of the vessel just below the elbow
by inflation of a sphygmomanometer to 300 mm Hg for
5 min. The cuff was then released. Imaging was initiated
30 s before release and continued for 5 min. The brachial
artery was allowed to return to baseline when a new baseline
diameter was measured. Then 0.3 mg of nitroglycerin
(NTG) was given sublingually, and the artery was imaged
for the next 6 min to measure endothelium-independent
nitroglycerin-mediated dilation (NMD). Ultrasound images
were recorded on Super-VHS videotapes and analyzed
off-line. A 1-cm linear segment of the artery was selected for
analysis; FMD (%) was defined as: 100  (peak post-cuff
deflation diameter  resting diameter)/resting diameter.
Nitroglycerin-mediated dilation (%) was defined as: 100 
(peak diameter post-NTG  resting diameter)/resting di-
ameter; FMD/NMD ratio was calculated by dividing peak
FMD by NMD. The variability of FMD and NMD
measurements from our laboratory have been reported (15).
For FMD, the intraobserver accuracies are 0.31% to
0.57% with precision of 1.50% to 1.97%. The interobserver
accuracy is 0.50% with a precision of 0.83%. For NMD, the
intraobserver accuracies are 1.27% to 0.16% with preci-
sion of 2.45% to 3.97%. The interobserver accuracy is
1.41% with a precision of 3.68%.
Follow-up. Major adverse cardiovascular events were de-
fined as death from vascular cause, acute vascular events
including cerebrovascular, cardiovascular (MI and unstable
angina requiring hospitalization), peripheral vascular events
(new onset of claudication), and symptom-driven revascu-
larization procedures (carotid endarterectomy, PTCA, or
CABG). Revascularization was recommended at the discre-
tion of the patients’ personal physician, without knowledge
of carotid or endothelial dysfunction measurements or other
input from the risk reduction clinic and based on clinically
significant worsening of symptoms or new onset of signif-
icant symptoms of ischemia. Cerebrovascular events were
defined as transient or permanent neurological dysfunction
verified by a neurologist. Acute MI was defined as elevation
Abbreviations and Acronyms
CABG coronary artery bypass grafting
CAD  coronary artery disease
EST  exercise stress test
FMD  flow-mediated dilation
HDL  high-density lipoprotein
IMT  intima medial thickness
LDL  low-density lipoprotein
MI  myocardial infarction
NMD  nitroglycerin-mediated dilation
NTG  nitroglycerin
PTCA  percutaneous coronary angioplasty
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in creatine kinase or troponin I 2 times the upper limit
of normal with or without electrocardiogram changes
(ST-segment elevations0.1 mV in2 contiguous leads or
new left bundle branch block).
Statistical analysis. Results were expressed as mean  SD
or interquartile range. Mann-Whitney U test was used for
comparison between variables. Correlations were defined
using Pearson correlation coefficient. Univariate and multi-
variate analyses using Cox stepwise forward regression
techniques were used to examine the associations between
variables and vascular events during follow-up. The contin-
uous variables included in the model were age, ejection
fraction, carotid IMT, total thickness, total area, plaque
thickness, plaque area, brachial FMD and NMD, FMD/
NMD ratio, total cholesterol, low-density lipoprotein
(LDL), high-density lipoprotein (HDL), triglycerides, total
cholesterol/HDL ratio, LDL/HDL ratio, non–HDL-
cholesterol, apolipoprotein B, homocysteine, lipoprotein (a),
fasting glucose, creatinine, resting systolic and diastolic
blood pressure, maximal workload on stress test, peak
exercise heart rate and blood pressure, weight, body mass
index, waist circumference, and waist-to-hip ratio. High
sensitivity C-reactive protein analyses were not being per-
formed at the time of initiation of enrollment of this cohort.
Categorical variables were gender, presence of angina, use of
statin, other lipid-lowering drugs, beta-blockers, long-
acting NTG, acetylsalicylic acid, calcium channel blockers,
angiotensin-converting enzyme inhibitors, vitamin E, vita-
min C, other multivitamins, folic acid, other supplements.
The interaction between carotid ultrasound and brachial
endothelial function variables was examined with a chi-
square contingency table. A value of p  0.05 was consid-
ered significant for comparison between means and chi-
square contingency testing. A p value of 0.15 with univariate
analysis was required for entry into the multivariate model
with a final p value of  0.1 indicating significance in
consideration of the large number of variables and the
overall sample size (16). Correlation coefficients with p 
0.01 were considered significant in identifying associations
between variables. A Cox proportional hazards model was
used to address whether changes in endothelial dysfunction
or carotid ultrasound measurements predicted an adverse
cardiac event. The percent changes, from measurements
taken at baseline, were considered for each covariate. For
those patients who experienced a cardiac event, only covari-
ate values before the event were considered.
RESULTS
Patient characteristics. A total of 152 subjects were re-
cruited. Demographic and other features are summarized in
Table 1. Carotid ultrasound and brachial endothelial func-
tion results are shown in Table 2. Focal carotid plaques were
found in 118 subjects (77.6%).
Relationship between variables. Relationships among dif-
ferent parameters of carotid ultrasound and endothelial
function are presented in Table 3. Carotid IMT did not
correlate with plaque thickness or area. There was no
correlation between peak FMD, NMD, or FMD/NMD
ratio with IMT or plaque measurements. There was also no
correlation between IMT, plaques, brachial FMD, NMD,
FMD/NMD ratio with any biochemical, anthropometric,
blood pressure, or stress test variable (data not shown).
Predictors of adverse vascular events. During 34  10
months of follow-up, 22 major, adverse cardiac events were
identified in 22 patients. There were 1 death, 8 acute
coronary syndromes (7 MI, 1 unstable angina), 2 neurolog-
ical events (1 transient ischemic attack, 1 cerebrovascular
accident), and 11 revascularization procedures (5 coronary
angioplasties, 5 coronary bypass surgeries, 1 carotid endar-
terectomy). Peak brachial FMD and FMD/NMD ratio
were lower in subjects with events (p  0.012 and p 
0.008, respectively) (Fig. 1). None of the carotid ultrasound
variables was significantly different between subjects with
and without events.
Univariate analysis with Cox proportion hazard modeling
Table 1. Baseline Subject Characteristics
Age (yrs) 55.9  6.2
Gender (male/female) 131/21
Previous MI (%) 53.3
Previous PTCA (%) 48.0
Previous CABG (%) 25.7






History of hypertension (%) 42.3
History of diabetes mellitus 11.5
Laboratory analysis
Total cholesterol (mmol/l) 4.67  0.97
LDL (mmol/l) 2.72  0.83
HDL (mmol/l) 1.17  0.33
Triglycerides (mmol/l) 1.69  0.95
Apolipoprotein B (mg/l) 0.95  0.24
Glucose (mmol/l) 5.5  1.1
Creatinine (mmol/l) 88  17
Lipoprotein (a) (mg/l) 480  499
Homocysteine (mmol/l) 8.5  2.5
Blood pressure
Systolic (mm Hg) 128  16
Diastolic (mm Hg) 80  7
Maximal workload on stress test (METS) 11.7  2.9
Weight (kg) 84.1  14.9
Body mass index 28.0  4.1
Waist circumference (cm) 94.1  11.4
Medications
Angiotensin-converting enzyme inhibitor (%) 29.5
Aspirin (%) 91.0
Beta-blocker (%) 48.1
Calcium channel blocker (%) 28.2
Statin (%) 76.3
Nitrate (%) 7.7
CABG  coronary artery bypass grafting; HDL  high-density lipoprotein; LDL 
low-density lipoprotein; METSmetabolic equivalent; MImyocardial infarction;
PTCA  percutaneous transluminal coronary angioplasty.
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selected peak FMD (p  0.03), FMD/NMD ratio (p 
0.005), plaque area (p  0.09), total area (p  0.09), plaque
thickness (p  0.11), diastolic blood pressure (p  0.13),
EST workload (p  0.027), NTG (p  0.03), and calcium
channel blockers (p  0.06) for entry into a multivariate
model. Multivariate analysis identified FMD/NMD ratio
(p 0.0001), plaque area (p 0.06), and use of long-acting
NTG (p  0.005) as independent predictors of events.
Figures 2 and 3 show the survival curves using tertiles for
FMD/NMD and plaque area. Figure 4 shows outcomes
stratified with respect to the median values of these two
measurements. Event rates of less than 5 per 100 patient-
years were seen in patients with high FMD/NMD (0.34),
irrespective of atheroma burden. The highest event rate (9.4
per 100 patient-years) was seen in patients with poor
FMD/NMD (0.34) and a high plaque area (6.59 mm2).
This high rate was significantly greater than in the subgroup
with high plaque area and preserved endothelial function (p
 0.05). Analysis of changes in endothelial dysfunction or
carotid ultrasound measurements during follow-up was
undertaken in patients who had at least one reassessment
before an event. Endothelial function and carotid ultra-
sound results obtained after an event could not be included
in this analysis of change. Based on 106 patients and 8
events, we found that deterioration of endothelial dysfunc-
tion was predictive of adverse cardiac events (p  0.05 for
change in FMD, p  0.071 for change in FMD/NMD),
whereas changes in carotid ultrasound measurements were
not (p  0.53 for change in IMT and p  0.73 for change
in plaque).
DISCUSSION
The main finding in this investigation is the demonstration
of the concomitant prognostic importance of vasodilatory
endothelial dysfunction and atheroma burden, both mea-
sured noninvasively in coronary patients. The degree of
endothelial dysfunction at baseline and its change during
follow-up was more discriminating than carotid measures
regarding outcome. The prognostic value of atheroma
burden was also modulated by the degree of endothelial
dysfunction. The results support the concept that both
structural and functional properties of the vasculature are
key co-determinants of cardiovascular outcome.
The prognostic importance of endothelial dysfunction
noted in this study is in keeping with the results of several
other studies (3–11). However, this paper provides infor-
mation not previously available. No study to date has
examined the independent value of noninvasive endothelial
function assessment in comparison with stress testing and
carotid ultrasound for risk stratification. Even more impor-
tantly, the prognostic importance of endothelial dysfunction
measurements and carotid ultrasound analyses were evalu-
ated while taking into account multiple biochemical and
physical measurements in a group of patients at high risk on
the basis of established CAD.
Table 2. Carotid Atherosclerosis and Brachial Artery Endothelial Function Studies
Range Mean  SD Median IQR
Carotid artery
IMT (mm) 0.632–1.268 0.865  0.135 0.865 0.773–0.956
Plaque thickness (mm) 0.00–17.38 3.22  3.02 2.42 1.15–4.88
Plaque area (mm2) 0.00–92.09 6.13  10.68 6.59 0.24–7.79
Total thickness (mm) 0.64–2.05 1.06  0.25 1.03 0.89–1.20
Total area (mm2) 12.76–159.77 28.48  16.68 25.14 19.26–32.09
Brachial artery
Peak FMD (%) 0.4–27.1 5.93  3.80 5.25 3.35–8.13
NMD (%) 1.0–37.9 15.98  6.70 15.65 11.9–19.5
FMD/NMD ratio 0.04–1.54 0.40  0.24 0.34 0.25–0.53
FMD  flow-mediated dilation; IMT  intima medial thickness; IQR  interquartile range; NMD  nitroglycerin-mediated
thickness.
Table 3. Pearson Correlation Coefficients Between Carotid Artery Ultrasound and Brachial














Plaque area 0.021 0.807
Total thickness 0.513 0.760 0.783
Total area 0.233 0.841 0.968 0.875
Peak FMD 0.195 0.145 0.140 0.218 0.175
NMD 0.078 0.120 0.100 0.138 0.115 0.437
FMD/NMD ratio 0.163 0.002 0.074 0.110 0.099 0.588 0.319
Values in bold indicate significant correlation.
Abbreviations as in Table 2.
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The FMD/NMD ratio at baseline was a more powerful
predictor of vascular events than baseline FMD, whereas
during follow-up, both change in FMD and change in
FMD/NMD were significant predictors, and FMD deteri-
oration was slightly more significantly associated with ad-
verse events than FMD/NMD. These results may have
occurred because the parameters were significantly corre-
lated with each other (Table 3), and so the slight differences
do not represent a difference in concept. However, we
believe that the baseline results are more robust than those
during follow-up because only measurements made before
events could be considered in the statistical model of
changes detected during follow-up, thereby diminishing
statistical power. We do suggest that the FMD/NMD ratio
has some advantages; NMD may be slightly impaired in
subjects with endothelial dysfunction, but this may not be
evident except in very large groups (17). We did not find a
difference between the NMD of patients suffering or not
suffering events during follow-up, but we did note a signif-
icant correlation between NMD and FMD (Table 3). In
contrast, there was no correlation between NMD and
FMD/NMD, suggesting that this ratio is a convenient way
to express specifically endothelium-dependent vasodilation.
Thus, the link between reduced FMD/NMD ratio and
future vascular events suggests that the portion of vascular
dilation specifically related to an endothelial mechanism and
not a smooth muscle (endothelium-independent) mecha-
nism is most important. Our results are also consistent with
Figure 1. Box plots (median and 25th to 75th interquartile range) of brachial artery endothelial function variables between subjects with and without
vascular events. Peak flow-mediated dilation (FMD) and FMD/nitroglycerin-mediated dilation (NMD) ratio were significantly lower in subjects with
events compared with subjects without events. There was no difference in NMD between subjects with and without events.
Figure 2. Event-free survival curves for tertiles of flow-mediated dilation
(FMD)/nitroglycerin-mediated dilation (NMD) ratio. There is a graded
response between FMD/NMD ratio tertiles and risk of adverse vascular
events. Lower FMD/NMD ratio is associated with higher risk of adverse
events.
Figure 3. Event-free survival curves for tertiles of carotid plaque area.
There is a graded response between carotid plaque area tertiles and risk of
adverse vascular events. Higher carotid plaque areas are associated with
increased risk of adverse events.
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previous literature demonstrating the utility of the FMD/
NMD ratio (18–20).
The prognostic importance of carotid ultrasound mea-
sures of atherosclerosis is well recognized (21,22), and
correlative analyses between endothelial dysfunction tests
and IMT have been published (23,24). There are, however,
no prior studies that compare the relative prognostic impor-
tance of carotid analysis and endothelial function in the
same study. We showed that both were independent pre-
dictors, but endothelial dysfunction was statistically more
strongly related to outcome; it provided better discrimina-
tory information with respect to event-free survival (Fig. 2),
and it modulated the outcome for any degree of atheroma
burden (Fig. 4) in patients with coronary disease. Our
results also suggest that plaque formation, and not IMT per
se, is the most important feature of carotid ultrasound that
is associated with risk factors and a poor outcome (12,25).
Our method of IMT measurement specifically excludes
focal plaques, thereby allowing an evaluation of which
ultrasound feature is contributing most to the predictive
model; IMT alone was not predictive of future adverse
events. The parameters that integrated IMT and plaque
measurements did not provide further prognostic value than
plaque assessment alone. These results are concordant with
the conclusions of other groups (22,25). The lack of a
significant relationship between carotid changes during
follow-up should be interpreted cautiously due to the
decreased number of patients and events upon which these
analyses were based, the protracted period of time required
to induce structural changes, and the fact that all patients
were receiving treatment that could have impeded plaque
progression.
We found that long-acting NTG at enrollment was an
independent predictor of future adverse events. The Fourth
International Study of Infarct Survival (ISIS-4) study
showed that use of nitrates post-MI had no short-term
benefit (26). Long-term usage was associated with increased
MI, death from heart failure, and sudden death (27).
Although it is possible that long-acting NTG was a surro-
gate of more symptomatic disease in our patients, we do not
think that this is likely, as the presence of angina was not
predictive of adverse cardiac events. Finally, this finding
should be interpreted with caution, as the use of long-acting
NTG was not randomized, and there were only 12 subjects
using it.
We should emphasize that the majority of our subjects
were treated for hyperlipidemia and hypertension and were
physically fit (Table 1). This probably contributes to the
apparent lack of association of traditional risk factors (e.g.,
lipids and blood pressure values, waist circumference, etc.),
other assays (e.g., apolipoprotein B, lipoprotein [a]), or
medications associated with improved prognosis (e.g.,
statins, angiotensin-converting enzyme inhibitors) with ad-
verse events in the multivariate model, or with carotid and
endothelial measurements. This may also account for the
low-event rate, a rate that is similar, however, to that noted
in another study of patients with stable coronary disease
evaluated with carotid ultrasound (28). This study did not
assess coronary angiographic burden of disease but only
carotid atheroma burden. Whether coronary angiographic
assessment would negate the prognostic value of endothelial
dysfunction measurement is not clear. For example, Heitzer
et al. (3), using intrabrachial infusion of acetylcholine,
Schachinger et al. (7), using several different methods
applied at the time of coronary angiography, and Halcox et
al. (5), using coronary infusions of acetylcholine at the time
of catheterization, all reported that endothelial dysfunction
measures were of independent prognostic importance in
patients with coronary disease even when considered with
respect to the number of coronary vessels with angiographic
stenosis. The only study that came to a different conclusion
was that of Neunteufl et al. (9).
Carotid plaque formation reflects the propensity for
atherosclerosis development in response to previous, long-
standing exposure to risk factors. In contrast, endothelial
dysfunction may give a better reflection of on-going pro-
cesses affecting the functional status of the vasculature.
Acute intervention studies of risk factors show that endo-
thelial function is dynamic and responds quickly to changes
in the internal milieu of the artery (29,30). The therapeutic
importance of this was recently underscored by Modena et
al. (6) who showed that, in patients treated equally well with
respect to hypertension, the status of endothelial function at
six months after initiation of treatment was predictive of
future events. Our finding that deterioration of endothelial
function correlated with adverse events in spite of treatment
during follow-up are consistent with their observations.
In conclusion, the noninvasive measurement of endothe-
lial dysfunction is an important and independent predictor
of the outcome of patients with CAD. This aspect of
vascular function modulates the impact of atheroma burden
as measured noninvasively by carotid ultrasound. These
Figure 4. Interaction between plaque burden and endothelial function in
prediction of future adverse vascular events. Patients with high flow-
mediated dilation (FMD)/nitroglycerin-mediated dilation (NMD)
(0.34) had low event rates irrespective of the plaque area. The highest
event rate was seen in patients with a high plaque burden (6.59 mm2) and
low FMD/NMD (0.34) (p  0.05).
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structural and functional measurements are fundamental
determinants of the prognosis of patients with CAD.
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